Climb Bio, Inc. (CLYM) ownership: Entities affiliated with RA Capital 33% · institutions 114% · index and ETF funds 2% (13F 2026-06-30). Insider activity, 90 days: Routine (1 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 11300939.00 | $147.36M | 19.7% | 2026-06-30 |
| FMR (Fidelity) | 6790364.00 | $88.55M | 11.8% | 2026-06-30 |
| UBS | 3404866.00 | $44.40M | 5.9% | 2026-06-30 |
| Braidwell LP | 2797375.00 | $36.48M | 4.9% | 2026-06-30 |
| Adage Capital Partners Gp, L.l.c. | 2506000.00 | $32.68M | 4.4% | 2026-06-30 |
| BlackRock | 2354872.00 | $30.71M | 4.1% | 2026-06-30 |
| Vanguard | 2143413.00 | $27.95M | 3.7% | 2026-06-30 |
| Price T Rowe Associates Inc | 2127281.00 | $27.74M | 3.7% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-29 | |
| Sell | null | 2026-06-29 | |
| Sell | null | 2026-06-27 | |
| Sell | null | 2026-06-27 | |
| Sell | null | 2026-06-27 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 |
Back to CLYM overview · CLYM earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.